Rosen Quoted on Generic Drug Guidelines

27 October 2011 Bloomberg News News
Foley Partner David Rosen was quoted in an article that appeared in Bloomberg News on October 27, 2011 titled "FDA tightens standards to prove generics can be swapped." Rosen discusses in-progress FDA guidelines that will impose tighter standards for generic drug makers. He states that the guidelines will potentially require companies conducting generic equivalence studies to recruit nearly twice as many people for testing, adding that a new equivalency study would require several months to test generic products against the original versions.

Related Services


Hatch Comments on DNC-Related Construction Projects in Milwaukee
14 June 2019
Milwaukee Business Journal
Bernard Quoted on Debt-Relief Settlement with ITT Tech Lender
14 June 2019
Wall Street Journal
Dodd and Daughter Profiled in Wisconsin Golf
13 June 2019
Wisconsin Golf
Brinckerhoff Comments on SCOTUS Ruling in Patent Case
11 June 2019
Intellectual Property Magazine
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
2019 NDI Executive Exchange
14-15 November 2019
Chicago, IL
Association for Corporate Counsel Annual Meeting 2019
27-30 October 2019
Phoenix, AZ
Foley's Government Contracts Annual Update
16 October 2019
Liviona, MI